vs
GRIFFON CORP（GFF）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
GRIFFON CORP的季度营收约是Royalty Pharma plc的1.0倍（$649.1M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 9.9%，领先24.5%），Royalty Pharma plc同比增速更快（4.8% vs 2.6%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs -1.8%）
格里芬公司是总部位于纽约的跨国多元化控股集团，业务覆盖多领域运营，旗下拥有Ames True Temper、ClosetMaid、Clopay建筑产品和CornellCookson四大子公司。该公司1961年起在纽交所公开上市，是标普小盘600指数、标普1500综合指数及罗素2000指数的成分股。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
GFF vs RPRX — 直观对比
营收规模更大
GFF
是对方的1.0倍
$622.0M
营收增速更快
RPRX
高出2.1%
2.6%
净利率更高
RPRX
高出24.5%
9.9%
两年增速更快
RPRX
近两年复合增速
-1.8%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $649.1M | $622.0M |
| 净利润 | $64.4M | $214.2M |
| 毛利率 | 41.1% | — |
| 营业利润率 | 17.5% | 62.4% |
| 净利率 | 9.9% | 34.4% |
| 营收同比 | 2.6% | 4.8% |
| 净利润同比 | -9.1% | 2.9% |
| 每股收益（稀释后） | $1.41 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GFFRPRX
| Q4 25 | $649.1M | $622.0M | ||
| Q3 25 | $662.2M | $609.3M | ||
| Q2 25 | $613.6M | $578.7M | ||
| Q1 25 | $611.7M | $568.2M | ||
| Q4 24 | $632.4M | $593.6M | ||
| Q3 24 | $659.7M | $564.7M | ||
| Q2 24 | $647.8M | $537.3M | ||
| Q1 24 | $672.9M | $568.0M |
净利润GFFRPRX
| Q4 25 | $64.4M | $214.2M | ||
| Q3 25 | $43.6M | $288.2M | ||
| Q2 25 | $-120.1M | $30.2M | ||
| Q1 25 | $56.8M | $238.3M | ||
| Q4 24 | $70.9M | $208.2M | ||
| Q3 24 | $62.5M | $544.0M | ||
| Q2 24 | $41.1M | $102.0M | ||
| Q1 24 | $64.1M | $4.8M |
毛利率GFFRPRX
| Q4 25 | 41.1% | — | ||
| Q3 25 | 41.7% | — | ||
| Q2 25 | 43.2% | — | ||
| Q1 25 | 41.2% | — | ||
| Q4 24 | 41.8% | — | ||
| Q3 24 | 39.9% | — | ||
| Q2 24 | 38.5% | — | ||
| Q1 24 | 40.2% | — |
营业利润率GFFRPRX
| Q4 25 | 17.5% | 62.4% | ||
| Q3 25 | 18.0% | 70.1% | ||
| Q2 25 | -20.5% | 36.3% | ||
| Q1 25 | 16.5% | 94.0% | ||
| Q4 24 | 17.7% | 60.9% | ||
| Q3 24 | 16.9% | — | ||
| Q2 24 | 13.8% | 50.2% | ||
| Q1 24 | 16.9% | -13.0% |
净利率GFFRPRX
| Q4 25 | 9.9% | 34.4% | ||
| Q3 25 | 6.6% | 47.3% | ||
| Q2 25 | -19.6% | 5.2% | ||
| Q1 25 | 9.3% | 41.9% | ||
| Q4 24 | 11.2% | 35.1% | ||
| Q3 24 | 9.5% | 96.3% | ||
| Q2 24 | 6.3% | 19.0% | ||
| Q1 24 | 9.5% | 0.8% |
每股收益（稀释后）GFFRPRX
| Q4 25 | $1.41 | $0.49 | ||
| Q3 25 | $1.04 | $0.67 | ||
| Q2 25 | $-2.65 | $0.07 | ||
| Q1 25 | $1.21 | $0.55 | ||
| Q4 24 | $1.49 | $0.46 | ||
| Q3 24 | $1.29 | $1.21 | ||
| Q2 24 | $0.84 | $0.23 | ||
| Q1 24 | $1.28 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $95.3M | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $108.9M | $9.7B |
| 总资产 | $2.1B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资GFFRPRX
| Q4 25 | $95.3M | $618.7M | ||
| Q3 25 | $99.0M | $938.9M | ||
| Q2 25 | $107.3M | $631.9M | ||
| Q1 25 | $127.8M | $1.1B | ||
| Q4 24 | $152.0M | $929.0M | ||
| Q3 24 | $114.4M | $950.1M | ||
| Q2 24 | $133.5M | $1.8B | ||
| Q1 24 | $123.0M | $843.0M |
总债务GFFRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | $1.5B | $8.0B | ||
| Q1 25 | $1.5B | $7.6B | ||
| Q4 24 | $1.5B | $7.6B | ||
| Q3 24 | $1.5B | $7.6B | ||
| Q2 24 | $1.5B | $7.6B | ||
| Q1 24 | $1.6B | $6.1B |
股东权益GFFRPRX
| Q4 25 | $108.9M | $9.7B | ||
| Q3 25 | $74.0M | $9.6B | ||
| Q2 25 | $63.9M | $9.5B | ||
| Q1 25 | $214.7M | $9.8B | ||
| Q4 24 | $227.8M | $10.3B | ||
| Q3 24 | $224.9M | $10.3B | ||
| Q2 24 | $223.5M | $9.8B | ||
| Q1 24 | $202.2M | $9.9B |
总资产GFFRPRX
| Q4 25 | $2.1B | $19.6B | ||
| Q3 25 | $2.1B | $19.3B | ||
| Q2 25 | $2.1B | $18.3B | ||
| Q1 25 | $2.3B | $17.6B | ||
| Q4 24 | $2.3B | $18.2B | ||
| Q3 24 | $2.4B | $18.0B | ||
| Q2 24 | $2.4B | $17.7B | ||
| Q1 24 | $2.4B | $16.1B |
负债/权益比GFFRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | 22.71× | 0.84× | ||
| Q1 25 | 7.16× | 0.78× | ||
| Q4 24 | 6.48× | 0.74× | ||
| Q3 24 | 6.78× | 0.74× | ||
| Q2 24 | 6.74× | 0.78× | ||
| Q1 24 | 7.84× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $107.0M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $99.3M | — |
| 自由现金流率自由现金流/营收 | 15.3% | — |
| 资本支出强度资本支出/营收 | 1.2% | — |
| 现金转化率经营现金流/净利润 | 1.66× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $278.9M | — |
8季度趋势，按日历期对齐
经营现金流GFFRPRX
| Q4 25 | $107.0M | $827.1M | ||
| Q3 25 | $75.0M | $702.6M | ||
| Q2 25 | $123.1M | $364.0M | ||
| Q1 25 | $16.5M | $596.1M | ||
| Q4 24 | $142.9M | $742.5M | ||
| Q3 24 | $72.1M | $703.6M | ||
| Q2 24 | $122.1M | $658.2M | ||
| Q1 24 | $39.8M | $664.6M |
自由现金流GFFRPRX
| Q4 25 | $99.3M | — | ||
| Q3 25 | $62.4M | — | ||
| Q2 25 | $114.4M | — | ||
| Q1 25 | $2.8M | — | ||
| Q4 24 | $125.5M | — | ||
| Q3 24 | $51.6M | — | ||
| Q2 24 | $107.5M | — | ||
| Q1 24 | $20.8M | — |
自由现金流率GFFRPRX
| Q4 25 | 15.3% | — | ||
| Q3 25 | 9.4% | — | ||
| Q2 25 | 18.6% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 19.8% | — | ||
| Q3 24 | 7.8% | — | ||
| Q2 24 | 16.6% | — | ||
| Q1 24 | 3.1% | — |
资本支出强度GFFRPRX
| Q4 25 | 1.2% | — | ||
| Q3 25 | 1.9% | — | ||
| Q2 25 | 1.4% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | 2.8% | — | ||
| Q3 24 | 3.1% | — | ||
| Q2 24 | 2.2% | — | ||
| Q1 24 | 2.8% | — |
现金转化率GFFRPRX
| Q4 25 | 1.66× | 3.86× | ||
| Q3 25 | 1.72× | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | 0.29× | 2.50× | ||
| Q4 24 | 2.02× | 3.57× | ||
| Q3 24 | 1.15× | 1.29× | ||
| Q2 24 | 2.97× | 6.45× | ||
| Q1 24 | 0.62× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GFF
| Consumer And Professional Products | $241.1M | 37% |
| Residential Repairand Remodel | $202.1M | 31% |
| International Excluding North America | $97.8M | 15% |
| Retail | $47.3M | 7% |
| Residential New Construction | $32.5M | 5% |
| Other | $14.2M | 2% |
| Industrial | $14.1M | 2% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
